12:00 AM
 | 
May 10, 1999
 |  BC Week In Review  |  Company News  |  Deals

Dendreon, Kirin deal

The partners expanded their 1998 license agreement under which Kirin's Pharmaceutical Division and Dendreon are developing dendritic cell-based immunotherapies to...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >